A study that injected dendritic-cell-derived exosomes expressing AFP into the HCC mouse model found that DEXAFP was thought to induce a strong antigen-specific immune response, which significantly inhibited the HCC occurrence in mice (79). The gene discussed is AFP; the disease is hepatocellular carcinoma.